Michal Geva

Title: Michal Geva: Innovator in Viral Infection Treatment

Introduction

Michal Geva is a notable inventor based in Even Yehuda, Israel. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections and related disorders. With a total of 6 patents, his work has the potential to impact many lives.

Latest Patents

Geva's latest patents include innovative methods for treating viral infections. One of his notable inventions is a method for treating, reducing the incidence, suppressing, or inhibiting a viral infection, disease, disorder, or symptoms thereof in a subject in need. This method involves administering a selective S1R agonist, with a specific focus on COVID-19, utilizing pridopidine or its pharmaceutically acceptable salt. Another significant patent addresses the treatment of fragile X syndrome (FXS) or related disorders, which involves periodically administering a pharmaceutical composition containing an effective amount of pridopidine.

Career Highlights

Throughout his career, Michal Geva has worked with various organizations, including Prilenia Neurotherapeutics Ltd. and the Agency for Science, Technology and Research. His experience in these companies has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Geva has collaborated with esteemed professionals in his field, including Michael Hayden and Mahmoud Abdulhossein Pouladi. These collaborations have likely contributed to the advancement of his research and inventions.

Conclusion

Michal Geva's contributions to the treatment of viral infections and disorders highlight his innovative spirit and dedication to improving healthcare. His patents represent significant advancements in medical science, showcasing the potential for new therapies to emerge from his work.